Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Deng Qihui is a specialized healthcare brand and research entity focused on the treatment of vitiligo using Traditional Chinese Medicine (TCM) principles. Centered around the Beijing Deng Qihui Vitiligo Medical Research Institute, the organization develops and distributes proprietary herbal formulations and clinical protocols. The brand's core methodology, often referred to as "Deng's Vitiligo Treatment," emphasizes a holistic approach that combines internal immune regulation with external topical therapies to stimulate melanocyte activity. The company operates specialized medical research facilities and health management centers that provide clinical consultations and customized treatment plans for patients with various forms of depigmentation disorders. With a strong emphasis on dermatological research, Deng Qihui has established a significant presence in the Chinese TCM market for skin diseases. Their products are primarily derived from natural botanical sources and are integrated into a comprehensive care model for long-term disease management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Deng Qihui Brand.